BACKGROUND: The Continuous Performance Test (CPT) has emerged as the most commonly administered measure of sustained attention, but use of discrepant versions reduces the ability of researchers and clinicians to accurately draw cross-study conclusions. In an effort to standardize use of the CPT, this study compared four versions of the Identical Pairs CPT for their reliability and ability to discriminate between patients with schizophrenia and healthy volunteers. The relationship of performance on the different versions of the CPT with measures of psychopathology, functioning, and other aspects of cognition was also examined. METHODS: Performance on the 2-digit, 3-digit, 4-digit, and Shapes Identical Pairs CPT was assessed at three test sessions over five weeks, during which subjects also completed the Brief Assessment of Cognition in Schizophrenia (BACS) and questionnaires assessing psychopathology and functioning. RESULTS: All four CPTs discriminated between patients with schizophrenia and healthy volunteers, but there were no statistical differences in sensitivity among the versions. The 3-digit CPT showed non-statistical advantages in that it had high test-retest reliability, low potential for a ceiling effect, and a very low rate of false alarms. There were also moderate correlations between CPT performance and performance of the BACS subtests, but no significant correlations between CPT performance and measures of psychopathology and functioning. CONCLUSIONS: While all versions of the CPT tested here had good psychometric characteristics, the 3-digit CPT-IP has some advantages in repeated measures studies such as clinical trials.
RCT Entities:
BACKGROUND: The Continuous Performance Test (CPT) has emerged as the most commonly administered measure of sustained attention, but use of discrepant versions reduces the ability of researchers and clinicians to accurately draw cross-study conclusions. In an effort to standardize use of the CPT, this study compared four versions of the Identical Pairs CPT for their reliability and ability to discriminate between patients with schizophrenia and healthy volunteers. The relationship of performance on the different versions of the CPT with measures of psychopathology, functioning, and other aspects of cognition was also examined. METHODS: Performance on the 2-digit, 3-digit, 4-digit, and Shapes Identical Pairs CPT was assessed at three test sessions over five weeks, during which subjects also completed the Brief Assessment of Cognition in Schizophrenia (BACS) and questionnaires assessing psychopathology and functioning. RESULTS: All four CPTs discriminated between patients with schizophrenia and healthy volunteers, but there were no statistical differences in sensitivity among the versions. The 3-digit CPT showed non-statistical advantages in that it had high test-retest reliability, low potential for a ceiling effect, and a very low rate of false alarms. There were also moderate correlations between CPT performance and performance of the BACS subtests, but no significant correlations between CPT performance and measures of psychopathology and functioning. CONCLUSIONS: While all versions of the CPT tested here had good psychometric characteristics, the 3-digit CPT-IP has some advantages in repeated measures studies such as clinical trials.
Authors: Emma Yong; Mariapaola Barbato; David L Penn; Richard S E Keefe; Scott W Woods; Diana O Perkins; Jean Addington Journal: Psychiatry Res Date: 2014-04-12 Impact factor: 3.222
Authors: Christina Shen; Florin C Popescu; Eric Hahn; Tam T M Ta; Michael Dettling; Andres H Neuhaus Journal: Schizophr Bull Date: 2013-08-10 Impact factor: 9.306
Authors: Eric Hahn; Andrea Vollath; Tam T M Ta; Constanze Hahn; Linn K Kuehl; Michael Dettling; Andres H Neuhaus Journal: PLoS One Date: 2014-01-08 Impact factor: 3.240
Authors: Simon R O Nilsson; Pau Celada; Kim Fejgin; Jonas Thelin; Jacob Nielsen; Noemí Santana; Christopher J Heath; Peter H Larsen; Vibeke Nielsen; Brianne A Kent; Lisa M Saksida; Tine B Stensbøl; Trevor W Robbins; Jesper F Bastlund; Timothy J Bussey; Francesc Artigas; Michael Didriksen Journal: Psychopharmacology (Berl) Date: 2016-03-17 Impact factor: 4.530
Authors: Andrew W Bismark; Michael L Thomas; Melissa Tarasenko; Alexandra L Shiluk; Sonia Y Rackelmann; Jared W Young; Gregory A Light Journal: Transl Psychiatry Date: 2018-04-12 Impact factor: 6.222
Authors: Simon Ro Nilsson; Kim Fejgin; Francois Gastambide; Miriam A Vogt; Brianne A Kent; Vibeke Nielsen; Jacob Nielsen; Peter Gass; Trevor W Robbins; Lisa M Saksida; Tine B Stensbøl; Mark D Tricklebank; Michael Didriksen; Timothy J Bussey Journal: Cereb Cortex Date: 2016-08-09 Impact factor: 5.357